Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $5.685M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
REM | Ann: Trading Halt | 10:06 | 0 | 108 | |||
|
|||||||
REM | Ann: June 2025 Quarterly Activities and Cash Flow Report | 30/07/25 | 6 | 871 | |||
|
|||||||
REM | Ann: Results of General Meeting | 28/07/25 | 2 | 705 | |||
|
|||||||
REM | Ann: Notice of General Meeting | 07/07/25 | 5 | 1.8K | |||
|
|||||||
REM | Ann: Notification of cessation of securities - REM | 02/07/25 | 0 | 225 | |||
|
|||||||
REM | Virtual Plant | 23/06/25 | 3 | 1.7K | |||
|
|||||||
REM | Ann: Appointment of Joint Company Secretary | 13/06/25 | 0 | 284 | |||
|
|||||||
REM | Ann: Change of Registered Office | 19/05/25 | 0 | 284 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |